- Home
- IPDN vs CHEK Comparison
IPDN vs CHEK Comparison
Compare IPDN & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPDN
- CHEK
- Stock Information
- Founded
- IPDN 2003
- CHEK 2004
- Country
- IPDN United States
- CHEK Israel
- Employees
- IPDN N/A
- CHEK N/A
- Industry
- IPDN EDP Services
- CHEK Medical Electronics
- Sector
- IPDN Technology
- CHEK Health Care
- Exchange
- IPDN Nasdaq
- CHEK Nasdaq
- Market Cap
- IPDN 4.3M
- CHEK 4.0M
- IPO Year
- IPDN 2013
- CHEK 2015
- Fundamental
- Price
- IPDN $1.41
- CHEK $0.79
- Analyst Decision
- IPDN
- CHEK
- Analyst Count
- IPDN 0
- CHEK 0
- Target Price
- IPDN N/A
- CHEK N/A
- AVG Volume (30 Days)
- IPDN 413.6K
- CHEK 36.6K
- Earning Date
- IPDN 05-14-2025
- CHEK 05-14-2025
- Dividend Yield
- IPDN N/A
- CHEK N/A
- EPS Growth
- IPDN N/A
- CHEK N/A
- EPS
- IPDN N/A
- CHEK N/A
- Revenue
- IPDN $6,730,605.00
- CHEK N/A
- Revenue This Year
- IPDN N/A
- CHEK N/A
- Revenue Next Year
- IPDN N/A
- CHEK N/A
- P/E Ratio
- IPDN N/A
- CHEK N/A
- Revenue Growth
- IPDN N/A
- CHEK N/A
- 52 Week Low
- IPDN $0.97
- CHEK $0.56
- 52 Week High
- IPDN $18.90
- CHEK $3.04
- Technical
- Relative Strength Index (RSI)
- IPDN 41.34
- CHEK 57.41
- Support Level
- IPDN $1.01
- CHEK $0.65
- Resistance Level
- IPDN $1.38
- CHEK $0.71
- Average True Range (ATR)
- IPDN 0.24
- CHEK 0.06
- MACD
- IPDN 0.06
- CHEK 0.01
- Stochastic Oscillator
- IPDN 42.72
- CHEK 58.20
About IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the Professional Diversity Network (PDN) segment, which includes online professional networking communities with career resources for diverse cultural groups and employers looking to hire members; and the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization, the RemoteMore segment. The company generates majority of its revenue from PDN Segment.
About CHEK Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.